전자간증 및 자궁내성장제한에서 사람 백혈구 항원-G 발현의 분석 = Analysis of HLA-G expression in preeclampsia and intrauterine growth restriction

다국어 초록 (Multilingual Abstract)

Objective: To determine whether soluble HLA-G protein levels in plasma and/or HLA-G protein in placental tissues differ between women with gestational complications (preeclampsia and/or intrauterine growth restriction, IUGR) and women with normal pregnancies. Methods: A sandwich enzyme-linked immunosorbent assay was used to investigate the HLA-G expression level in 11 cases of preeclampsia, 8 cases of preeclampsia with IUGR, 18 cases of IUGR, and 10 normal control subjects. Results: Plasma HLA-G levels were decreased significantly in the preeclampsia group (median, 0.072 μg/mL), the preeclampsia with IUGR group (median, 0.086 μg/mL), and the IUGR group (median, 0.081 μg/mL), in comparison with normal pregnant women (median, 0.360 μg/mL) (P=0.002, P=0.049, and P=0.003, respectively). Also, Placental HLA-G levels were decreased significantly in the preeclampsia group (median, 0.016 μg/mg), the preeclampsia with IUGR group (median, 0.015 μg/mg), and the IUGR group (median, 0.021 μg/mg), in comparison with normal pregnant women (median, 0.091 μg/mg) (P<0.001, P=0.002, and P=0.001, respectively). There was a significant correlation between plasma and placental HLA-G levels (r=0.807, P<0.001). Conclusion: Our results indicate that the attenuated expression of placental HLA-G and reduced release of this protein into the maternal circulation in gestational complications, such as preeclampsia and IUGR may alter the maternal-fetal immune relationship, and thus could be at play in the pathophysiology of these diseases. This suggests that assessment of levels of HLA-G proteins may be useful in predicting development of preeclampsia and IUGR.

참고문헌 (Reference)

1 "of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre- eclampsia" 6 : 88-95, 2000

2 "expressed in human trophoblasts. Science 1990" 220-3,

3 "The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface" 47 : 1-16, 2000

4 "Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells" 189 : 1149-1156, 1999

5 "Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts" 59 : 435-442, 1998

6 "Serum and placenta HLA-G decreased in women with preeclampsia" 191 : 525-529, 2004

7 "Redman CW. Immunology of preeclampsia. Semin Perinatol 1991" 257-62,

8 "Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines" 38 : 79-82, 1997

9 "Pregnancy outcomes in ealthy nulliparas women who subsequently developed hypertension" 95 : 24-28, 2000

10 "Pre-eclampsia: physiology and immunological aspects" 61 : 85-97, 1995

11 "Placental pathology of fetal growth restriction" 40 : 740-749, 1997

12 "Peripartal temporal course of endothelin 1, angiotensin Ⅱ and atrial natriuretic peptide in pre-eclampsia and normotensive pregnancy" 13 : 309-314, 1998

13 "Pathophysiology of fetal growth restriction implications for diagnosis and surveillance" 59 : 617-627, 2004

14 "Multiple receptors for HLA-G on human natural killer cells" 94 : 1466-1470, 1997

15 "Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia" 20 : 738-743, 2000

16 "Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation" 190 : 1590-, 2004

17 "Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994" 1244-50,

18 "Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967" 159-63,

19 "Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy" 193 : 204-208, 2005

20 "Kristofova H. The use of murine monoclonal antibody B2M-01 for detection and purification of human beta 2-microglobulin. Folia Biol" 369-76, 1984

21 "Hypertensive disorder in Pregnancy" Seoul: McGraw-Hill Company 761-, 2005

22 "Human placental HLA-G expression is restricted to differentiated cytotrophoblasts" 154 : 3771-3778, 1995

23 "Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia" 151 : 1809-1818, 1997

24 "How do NK cells sense the expression of HLA-G class Ib molecules?" 9 : 19-26, 1999

25 "HLA-G molecules: from maternal-fetal tolerance to tissue acceptance" 81 : 199-252, 2003

26 "HLA-G levels in serum and plasma" 67 : 111-116, 2006

27 "HLA-G has a concentration-dependent effect on the generation of an allo-CTL response" 101 : 191-200, 2000

28 "HLA-G and immune tolerance in pregnancy" 19 : 681-693, 2005

29 "HLA-G and MIC expression in tumors and their role in anti-tumor immunity" 24 : 82-87, 2003

30 "Fisher SJ. Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994" 17125-31,

31 "Diagnosis and management of gestational hypertension and preeclampsia" 102 : 181-192, 2003

32 "Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy" 31 : 1841-1843, 1999

33 "Detection of HLA-G5 secreting cells" 64 : 1017-1024, 2003

34 "Current concepts in intrauterine growth restriction" 19 : 307-319, 2004

35 "Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules" 55 (55): 510-518, 2000

36 "Association of soluble HLA-G plasma levels with HLA-G alleles" 57 : 15-21, 2001

37 "Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody 87G and anti-cytokeratin antibody CAM5.2" 36 : 349-358, 1996

38 "Alteration of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy" 96 : 59-62, 2001

39 "Activin A and inhibin A as possible endocrine markers for pre- eclampsia" 349 : 1285-1288, 1997